Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Copper ion transport refers to the directed movement of copper (Cu) ions into, out of, or within a cell, or between cells. This process is mediated by specific transporter proteins or pores that ensure copper is delivered where needed for essential biological functions while preventing toxic accumulation. Key proteins include CTR1 (SLC31A1) for import, CTR2 (SLC31A2) for distribution, ATP7A and ATP7B for export, and metallo-chaperones like ATOX1, CCS, and COX17 for intracellular trafficking. Dysregulation of these transporters leads to disorders such as Menkes disease (ATP7A defect) and Wilson disease (ATP7B defect).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper Ion Transport.